Schizophrenia.com
Intra-Cellular pushes back on stereotypes in first DTC campaign for caplyta
News
everhopeful
September 15, 2020, 5:35pm
1
2 Likes
Wave
September 15, 2020, 5:47pm
2
I thought that the TV commercial was positive.
1 Like
Related topics
Topic
Replies
Views
Activity
Intra-Cellular Therapies Initiates Promotional Activities for CAPLYTA™ (lumateperone) for the Treatment of Schizophrenia in Adults
News
0
301
April 2, 2020
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
Medications
0
40
November 5, 2024
Intra-Cellular Therapies Announces Availability of CAPLYTA™ (lumateperone) for Adult Patients with Schizophrenia
News
6
522
March 23, 2020
Intra-Cellular's Caplyta scores again in major depressive disorder as blockbuster expansion comes within reach
Medications
11
197
June 20, 2024
Intra-Cellular's Caplyta Is Likely A Blockbuster For Bipolar Depression Barring Generic Entry
Medications
5
364
March 10, 2023